-
Science & technology
Science & technology
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
- Overview
- Our pipeline
- Matrix-M™ adjuvant
- Recombinant, protein-based nanoparticle vaccine
- Global vaccine approval/authorization map
COVID-19 UPDATESNovavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Who we are
Who we are
We are a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
Insights
Insights
Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.
Insights
Explore our library of ever-evolving insightful articles from experienced thought leaders on vaccines and addressing public health threats.
From pandemic to endemic: Why COVID-19 may be here to stay
December 2021
Understanding vaccine safety and efficacy in clinical trials
December 2021
Creating vaccines to help fight constantly changing threats
December 2021
Why do we need vaccine booster injections?
December 2021
Standing on the shoulders of giants: How a Novavax vaccine is developed
December 2021